Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
S.J. Spechler.
Barrett's esophagus.
N Engl J Med, 346 (2002), pp. 836-842
[2.]
J. Lagergren, R. Bergström, A. Lindgren, O. Nyrén.
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma.
N Engl J Med, 340 (1999), pp. 825-831
[3.]
W.K. Hirota, T.M. Loughney, D.J. Lazas, C.L. Maydonovitch, V. Rholl.
Wong RKH. Specialized intestinal metaplasia, dysplasia, and cancer of the esophagus and esophagogastric junction: prevalence and clinical data.
Gastroenterology, 116 (1999), pp. 277-285
[4.]
J. Alcedo, A. Lanas, A. Ferrández, F. Sopeña, J. Arenas.
Trends in the epidemiology and outcome of Barrett's esophagus in Spain.
Gut, 51 (2002), pp. 27
[5.]
C. Morales, R.F. Souza, S.J. Spechler.
Hallmarks of cancer progression in Barrett's oesophagus.
Lancet, 360 (2002), pp. 1587-1589
[6.]
V.N. Shirvani, R. Ouatu-Lascar, B.S. Kaur, B. Omary, G. Triadafilopoulos.
Cyclooxygenase 2 expression in Barrett's esophagus and adenocarcinoma: ex vivo induction by bile salts and acid exposure.
Gastroenterology, 118 (2000), pp. 487-496
[7.]
A.P. Weston, S.K. Banerjee, P. Sharma, T.M. Tran, R. Richards, R. Cherian.
p53 protein overexpression in low grade dysplasia (LGD) in Barrett's esophagus: immunohistochemical marker predictive of progression.
Am J Gastroenterol, 96 (2001), pp. 1355-1362
[8.]
B.J. Reid, D.S. Levine, G. Longton, P.L. Blount, P.S. Rabinovitch.
Predictors of progression to cancer in Barrett's esophagus: baseline histology and flow cytometry identify low-and highrisk patient subsets.
Am J Gastroenterol, 95 (2000), pp. 1669-1676
[9.]
R.E. Sampliner.
Updated guidelines for the diagnosis, surveillance and therapy of Barrett's esophagus.
Am J Gastroenterol, 97 (2002), pp. 1888-1895
[10.]
W. Ye, W.H. Chow, J. Lagergren, L. Yin, O. Nyren.
Risk of adenocarcinoma of the esophagus and gastric cardia in patients with gastroesophageal reflux diseases and after antireflux surgery.
Gastroenterology, 121 (2001), pp. 1286-1293
[11.]
J.A. Jankowski, D. Provenzale, P. Moayyedi.
Esophageal adenocarcinoma arising from Barrett's metaplasia has regional variations in the west.
Gastroenterology, 122 (2002), pp. 588-590
[12.]
P. Sharma.
An update on strategies for eradication of Barrett's mucosa.
Am J Med, 111 (2001), pp. 147-152
[13.]
J. Van den Boogert, R. Van Hillegersberg, P.D. Siersema, R.W.F. De Bruin, H.W. Tilanus.
Endoscopic ablation therapy for Barrett's esophagus with high-grade dysplasia: a review.
Am J Gastroenterol, 94 (1999), pp. 1153-1160
[14.]
B.F. Overholt, M. Panjehpour, J.M. Haydek.
Photodynamic therapy for Barrett's esophagus: follow-up in 100 patients.
Gastrointest Endosc, 49 (1999), pp. 1-7
[15.]
R.J. Pacifico, K.K. Wang.
Role of mucosal ablative therapy in the treatment of the columnar-lined esophagus.
Chest Surg Clin N Am, 12 (2002), pp. 185-203
[16.]
M.J. Langman, K.K. Cheng, E.A. Gilman, R.J. Lancashire.
Effect of anti-inflammatory drugs on overall risk of common cancer: case-control study in general practice research database.
Br Med J, 320 (2000), pp. 1642-1646
[17.]
G.P. Morgan, J.G. Williams.
Tumouricidal effect of indomethacin in the esophagus.
Postgrad Med J, 69 (1993), pp. 960
[18.]
N.S. Buttar, K.K. Wang, M.A. Anderson, R.A. Dierkhising, R.J. Pacifico, K.K. Krishnadath, et al.
The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epitelium: an in vitro study.
J Natl Cancer Inst, 94 (2002), pp. 422-429
[19.]
N.S. Buttar, K.K. Wang, O. Leontovich, J.Y. Westcott, R.J. Pacifico, M.A. Anderson, et al.
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitores in an animal model of Barrett's esophagus.
Gastroenterology, 122 (2002), pp. 1101-1112
[20.]
B.S. Kaur, N. Khamnehei, M. Iravani, S.S. Namburu, O. Lin, G. Triadafilopoulos.
Rofecoxib inhibits cyclooxygenase 2 expression and activity and reduces cell proliferation in Barrett's esophagus.
Gastroenterology, 123 (2002), pp. 60-67
[21.]
A. Lanas, F. Soteras, P. Jiménez, I. Fiteni, E. Piazuelo, Y. Royo, J. Ortego, et al.
Superoxide anion and nitric oxide in high-grade esophagitis induced by acid and pepsin in rabbits.
Dig Dis Sci, 46 (2001), pp. 2733-2743
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
